UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 220

Sortiert nach

I043 THE ROLE OF SURGERY IN RELAPSED OVARIAN CANCER

International journal of gynecology and obstetrics, 2012-10, Vol.119 (S3), p.S171-S171

Bidziński, M.

2012

Link zum Volltext

Verfügbarkeit prüfen

EP1195 Circulating microRNAs in differential diagnosis of vulvar intraepithelial lesions and vulvar squamous cell carcinoma

International journal of gynecological cancer, 2019-11, Vol.29 (Suppl 4), p.A616-A616

2019

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the constructed the device along with the software for digital archiving, sending the data and supporting the diagnosis of cervical cancer

Gynecologic oncology, 2019-06, Vol.154, p.272-273

2019

Link zum Volltext

Verfügbarkeit prüfen

265 Evaluation of the constructed the device along with the software for digital archiving, sending the data and supporting the diagnosis of cervical cancer

International journal of gynecological cancer, 2019-09, Vol.29 (Suppl 3), p.A112-A113

2019

Link zum Volltext

Verfügbarkeit prüfen

000370 EFFECTIVENESS OF INTERSTITIAL BRACHYTHERAPY HDR COMBINED WITH SURGERY IN ACHIEVING LOCAL CONTROL AND SPHINCTER PRESERVATION IN PATIENTS WITH ADVANCED CARCINOMA OF THE VULVA

International journal of gynecological cancer, 2005-09, Vol.15 (Suppl 2), p.153-153

2005

Link zum Volltext

Verfügbarkeit prüfen

Phase II randomized study of trabectedin given as two different every 3 weeks dose schedules (1.5 mg/m2 24 h or 1.3 mg/m2 3 h) to patients with relapsed, platinum-sensitive, advanced ovarian cancer

Annals of oncology, 2009-11, Vol.20 (11), p.1794-1802

2009

Link zum Volltext

Verfügbarkeit prüfen

Weekly AUC2 carboplatin in acquired platinum-resistant ovarian cancer with or without oral phenoxodiol, a sensitizer of platinum cytotoxicity: the phase III OVATURE multicenter randomized study

Annals of oncology, 2014-01, Vol.25 (1), p.160-165

2014

Link zum Volltext

Verfügbarkeit prüfen

Phase II randomized study of trabectedin given as two different every 3 weeks dose schedules (1.5 mg/m(2) 24 h or 1.3 mg/m(2) 3 h) to patients with relapsed, platinum-sensitive, advanced ovarian cancer

Annals of oncology, 2009-11, Vol.20 (11), p.1794

2009

Link zum Volltext

Verfügbarkeit prüfen

Analysis of the treatment of ovarian cancer patients with neo-adjuvant chemotherapy--preliminary results

European journal of gynaecological oncology, 2005, Vol.26 (4), p.423-426

2005

Link zum Volltext

Verfügbarkeit prüfen

CIRCULATING MICRORNAS IN DIFFERENTIAL DIAGNOSIS OF VULVAR INTRAEPITHELIAL LESIONS AND VULVAR SQUAMOUS CELL CARCINOMA: EP1195

International journal of gynecological cancer, 2019-11, Vol.29 ESGO Annual Meeting Abstracts, p.A616-A616

2019

Link zum Volltext

Verfügbarkeit prüfen

Adverse event profile by folate receptor status for vintafolide + pegylated liposomal doxorubicin vs pegylated liposomal doxorubicin alone in platinum-resistant ovarian cancer

Gynecologic oncology, 2014-06, Vol.133, p.178-178

2014

Link zum Volltext

Verfügbarkeit prüfen

CA-125 as a response marker for vintafolide + pegylated liposomal doxorubicin vs pegylated liposomal doxorubicin alone in platinum-resistant ovarian cancer: The PRECEDENT trial

Gynecologic oncology, 2014-06, Vol.133, p.177-178

2014

Link zum Volltext

Verfügbarkeit prüfen

Nijmegen breakage syndrome gene (NBS1) alterations and its protein (nibrin) expression in human ovarian tumours

Annals of human genetics, 2002-11, Vol.66 (5-6), p.353-359, Article S0003480002001227

2002

Link zum Volltext

Verfügbarkeit prüfen

European Society of Gynaecological Oncology Guidelines for the Management of Patients With Vulvar Cancer

International journal of gynecological cancer, 2017-05, Vol.27 (4), p.832-837

2017

Link zum Volltext

Verfügbarkeit prüfen

Cervical verrucous carcinoma involving endometrium. Case report

European journal of gynaecological oncology, 1999, Vol.20 (1), p.35

1999

Link zum Volltext

Verfügbarkeit prüfen

8029 POSTER Health-Related Quality of Life (HRQoL)/Patient Reported Outcomes (PRO) of Patients (pts) With Partially Platinum Sensitive (PPS) Recurrent Ovarian Cancer (ROC) Treated in a Randomized Phase III Trial of Trabectedin and Pegylated Liposomal Doxorubicin (PLD) Vs PLD Alone (OVA-301) – an Exploratory Analysis

European journal of cancer (1990), 2011, Vol.47, p.S536-S536

2011

Link zum Volltext

Verfügbarkeit prüfen

PIK3CA mutations and amplification in endometrioid endometrial carcinomas: relation to other genetic defects and clinicopathologic status of the tumors

Human pathology, 2011-11, Vol.42 (11), p.1710-1719

2011

Link zum Volltext

Verfügbarkeit prüfen

The value of tumor marker and cytokine analysis for the assessment of regional lymph node status in cervical cancer patients

International journal of gynecological cancer, 2008-11, Vol.18 (6), p.1279-1284

2008

Link zum Volltext

Verfügbarkeit prüfen

8004 ORAL Safety and Efficacy Outcomes in Heavily and Non-heavily Pretreated Patients With Recurrent Ovarian Cancer (ROC) After Single-agent Trabectedin Treatment – Pooled Analysis of Phase II Trials

European journal of cancer (1990), 2011, Vol.47, p.S528-S529

2011

Link zum Volltext

Verfügbarkeit prüfen

0552: The Usefulness of ‘In Vivo’ Proton H1 Spectro-Scopy Mrs in Pretreatment Evaluation of Patients with Carcinoma of the Cervix

International journal of gynecological cancer, 2006-10, Vol.16 (Suppl 3), p.755-755

2006

Link zum Volltext

Verfügbarkeit prüfen

EP894 Evaluation of the clinical usefulness of HE4 and CA125 assays in monitoring treatment response of patients with advanced ovarian cancer

International journal of gynecological cancer, 2019-11, Vol.29 (Suppl 4), p.A483-A484

2019

Link zum Volltext

Verfügbarkeit prüfen

EP386 Cervical cancer screening in PHC organization in poland

International journal of gynecological cancer, 2019-11, Vol.29 (Suppl 4), p.A259-A259

2019

Link zum Volltext

Verfügbarkeit prüfen

44TiP ENGOT-ov65/KEYNOTE-B96: Phase III, randomized, double-blind study of pembrolizumab vs placebo + paclitaxel with optional bevacizumab for platinum-resistant recurrent ovarian cancer

Annals of oncology, 2022-06, Vol.33, p.S400-S401

2022

Link zum Volltext

Verfügbarkeit prüfen

Results of chemotherapy for pulmonary metastases of carcinoma of the cervix in patients after primary surgical and radiotherapeutic management

International journal of gynecological cancer, 2007-09, Vol.17 (5), p.1056-1061

2007

Link zum Volltext

Verfügbarkeit prüfen

Nijmegen breakage syndrome gene (NBS1) alterations and its protein (nibrin) expression in human ovarian tumours

Annals of human genetics, 2002-11, Vol.66 (5‐6), p.353-359

2002

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 220

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(194)
Mit Volltextzugriff
(152)

Publikationsform

Artikel
(219)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(86)
Life Sciences & Biomedicine
(84)
Male
(80)
Humans
(70)
Animals
(61)
Female
(60)
Rats
(57)
Adult
(49)
Middle Aged
(44)
Biological And Medical Sciences
(42)
Neurosciences & Neurology
(34)
Pharmacology & Pharmacy
(31)
Neurosciences
(30)
Rats, Wistar
(30)
Aged
(26)
Medical Sciences
(25)
Behavioral Sciences
(23)
Ovarian Cancer
(21)
Oncology
(19)
Fundamental And Applied Biological Sciences. Psychology
(18)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

I043 THE ROLE OF SURGERY IN RELAPSED OVARIAN CANCER

EP1195 Circulating microRNAs in differential diagnosis of vulvar intraepithelial lesions and vulvar squamous cell carcinoma

Evaluation of the constructed the device along with the software for digital archiving, sending the data and supporting the diagnosis of cervical cancer

265 Evaluation of the constructed the device along with the software for digital archiving, sending the data and supporting the diagnosis of cervical cancer

000370 EFFECTIVENESS OF INTERSTITIAL BRACHYTHERAPY HDR COMBINED WITH SURGERY IN ACHIEVING LOCAL CONTROL AND SPHINCTER PRESERVATION IN PATIENTS WITH ADVANCED CARCINOMA OF THE VULVA

Phase II randomized study of trabectedin given as two different every 3 weeks dose schedules (1.5 mg/m2 24 h or 1.3 mg/m2 3 h) to patients with relapsed, platinum-sensitive, advanced ovarian cancer

Weekly AUC2 carboplatin in acquired platinum-resistant ovarian cancer with or without oral phenoxodiol, a sensitizer of platinum cytotoxicity: the phase III OVATURE multicenter randomized study

Phase II randomized study of trabectedin given as two different every 3 weeks dose schedules (1.5 mg/m(2) 24 h or 1.3 mg/m(2) 3 h) to patients with relapsed, platinum-sensitive, advanced ovarian cancer

Analysis of the treatment of ovarian cancer patients with neo-adjuvant chemotherapy--preliminary results

CIRCULATING MICRORNAS IN DIFFERENTIAL DIAGNOSIS OF VULVAR INTRAEPITHELIAL LESIONS AND VULVAR SQUAMOUS CELL CARCINOMA: EP1195

Adverse event profile by folate receptor status for vintafolide + pegylated liposomal doxorubicin vs pegylated liposomal doxorubicin alone in platinum-resistant ovarian cancer

CA-125 as a response marker for vintafolide + pegylated liposomal doxorubicin vs pegylated liposomal doxorubicin alone in platinum-resistant ovarian cancer: The PRECEDENT trial

Nijmegen breakage syndrome gene (NBS1) alterations and its protein (nibrin) expression in human ovarian tumours

European Society of Gynaecological Oncology Guidelines for the Management of Patients With Vulvar Cancer

Cervical verrucous carcinoma involving endometrium. Case report

PIK3CA mutations and amplification in endometrioid endometrial carcinomas: relation to other genetic defects and clinicopathologic status of the tumors

The value of tumor marker and cytokine analysis for the assessment of regional lymph node status in cervical cancer patients

8004 ORAL Safety and Efficacy Outcomes in Heavily and Non-heavily Pretreated Patients With Recurrent Ovarian Cancer (ROC) After Single-agent Trabectedin Treatment – Pooled Analysis of Phase II Trials

0552: The Usefulness of ‘In Vivo’ Proton H1 Spectro-Scopy Mrs in Pretreatment Evaluation of Patients with Carcinoma of the Cervix

EP894 Evaluation of the clinical usefulness of HE4 and CA125 assays in monitoring treatment response of patients with advanced ovarian cancer

EP386 Cervical cancer screening in PHC organization in poland

44TiP ENGOT-ov65/KEYNOTE-B96: Phase III, randomized, double-blind study of pembrolizumab vs placebo + paclitaxel with optional bevacizumab for platinum-resistant recurrent ovarian cancer

Results of chemotherapy for pulmonary metastases of carcinoma of the cervix in patients after primary surgical and radiotherapeutic management

Nijmegen breakage syndrome gene (NBS1) alterations and its protein (nibrin) expression in human ovarian tumours

Suchergebnisse filtern